Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

669
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
669
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

231
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
231
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

144
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
144
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

311
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
311
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

477
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
477

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Label-Free Quantification of Bilirubin Using a Refractive Index-Insensitive Nanolaminate SERS Substrate.

Biosensors·2026
Same author

Corrigendum to "Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling" [Mol. Cells 49 (2026) 100342].

Molecules and cells·2026
Same author

PKGPT: Expert-Orchestrated Recursive LLM Agent for Automated NONMEM PopPK Modeling with Human Benchmarking.

Pharmaceutics·2026
Same author

Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling.

Molecules and cells·2026
Same author

Flexible Bayesian Inference for Identifying Significantly Correlated Multiple Pathway Sets.

Statistics in medicine·2026
Same author

CaMKIV negatively regulates osteoblast differentiation by modulating c-Fos and NFATc1 signaling: an in vitro and in vivo mechanistic study.

BMB reports·2026
Same journal

Association between intestinal functional disorders and anal fistula: evidence from a retrospective case-control study.

PeerJ·2026
Same journal

Automated recognition of Meso-Cenozoic foraminifera from Senegalese sedimentary deposits using convolutional neural networks.

PeerJ·2026
Same journal

Genome-wide analysis of <i>HSP70</i> gene superfamily in kelp (<i>Saccharina japonica</i>): identification, characterization, and heat stress-responsive expression profiles.

PeerJ·2026
Same journal

Morphological and molecular evidence of the Antarctic sleeper shark <i>Somniosus antarcticus</i> (Somniosidae) in northern Chile.

PeerJ·2026
Same journal

Stroboscopic balance training enhances dynamic stability and postural control in collegiate badminton players: a randomized controlled trial.

PeerJ·2026
Same journal

Frequent exposure to biologics is associated with small intestinal bacterial overgrowth in patients with Crohn's disease: a retrospective case-control study.

PeerJ·2026
查看所有相关文章

相关实验视频

Updated: Jan 12, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.2K

PKPy:基于Python的框架,用于自动化人口药理动力学分析.

Hyunseung Kong1, Inyoung Kim2, Byoung-Tak Zhang1,3

  • 1Interdiciplinary Program Bioinformatics, Seoul National University, Seoul, Republic of South Korea.

PeerJ
|November 3, 2025
PubMed
概括
此摘要是机器生成的。

开源的Python框架PKPy自动化了人群药动力学分析,提供了用户友好的参数估计和强大的诊断. 与现有工具相比,它表现出高精度和计算效率.

关键词:
制药指标 (Pharmacometrics) 是一个指标.人口的药理动力学.在这里,Python是Python.

更多相关视频

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.7K
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.7K

相关实验视频

Last Updated: Jan 12, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.2K
Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.7K
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.7K

科学领域:

  • 药理动力学和药理计量学
  • 计算生物学 计算生物学
  • 药物开发 药物开发

背景情况:

  • 种群药动力学 (PopPK) 分析对于了解不同患者种群中的药物处置至关重要.
  • 现有的工具往往需要手动初始化参数,这对可访问性构成障碍,并可能影响分析的严谨性.
  • 自动化PopPK工作流可以提高药物开发的效率和可重复性.

研究的目的:

  • 引入PKPy,这是一个开源的Python框架,用于自动化人口药理动力学分析.
  • 为参数估计,共变量分析和诊断提供一个用户友好的,但在分析上严格的平台.
  • 评估PKPy的性能,并将其效率与已有的软件进行比较.

主要方法:

  • 开发了PKPy,实现了具有第一阶段吸收的1和2分隔模型.
  • 使用模拟研究评估的性能,样本大小各不相同 (20-100名受试者).
  • 将PKPy的安装和分析时间与Saemix+PKNCA和nlmixr2.2进行比较.

主要成果:

  • PKPy表现出强大的参数估计 (偏差<3%,回收>98%的单间模型).
  • 准确识别共变量关系 (100%) 和高模型匹配 (R2 ≥0.97).
  • PKPy显示出显著的计算优势,安装和分析时间更快.

结论:

  • PKPy为药理动力学分析提供了一个可访问,透明和高效的平台.
  • 该框架成功地自动化复杂的工作流程,同时保持科学严谨性.
  • PKPy有潜力降低进入药量分析的进入障碍.